OBI-3424
IV AKR1C3-activated cytotoxin prodrug Ph. I/II in advanced solid tumors prodrug of DNA cross-linking agent Br. J. Cancer, May 12, 2023 OBI Pharma, TW; Threshold Pharma, CA
Molecules of the Month - May 2023
IV AKR1C3-activated cytotoxin prodrug Ph. I/II in advanced solid tumors prodrug of DNA cross-linking agent Br. J. Cancer, May 12, 2023 OBI Pharma, TW; Threshold Pharma, CA
Molecules of the Month - May 2023